Nelipepimut-S
Product Specifications
UNSPSC Description
Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1].
Target Antigen
EGFR
Type
Peptides
Related Pathways
JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nelipepimut-s.html
Solubility
H2O
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@@H](NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CO)NC(CNC([C@@H](NC([C@H]([C@@H](C)CC)NC([C@@H](N)CCCCN)=O)=O)CC1=CC=CC=C1)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O
Molecular Weight
995.21
References & Citations
[1]Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press). 2020 Apr 3;12:69-75.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106204/Nelipepimut-S-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106204/
Clinical Information
Phase 3
CAS Number
160212-35-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
